JAMES HAWKINS - 11 Dec 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James B. Hawkins
Issuer symbol
IRMD
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
4
Filing time
12 Dec 2025, 17:00:18 UTC
Previous filing
10 Dec 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAWKINS JAMES B Director C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ James B. Hawkins 12 Dec 2025 0000898243

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +905 +3.1% 29,647 11 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -905 -50% $0.000000 906 11 Dec 2025 Common Stock 905 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.